Post Marketing Assessment is necessary to carry out after the approval of new drugs. Our experts closely monitor and will conduct a Post Marketing Assessment to prepare a Benefit-Risk Profile. It helps the manufacturer to analyze the established new drug's adverse reaction. Our team members also help the sponsors to submit the regulatory compliance related to post-marketing assessment including PSURs.